Profil
Karen Chagin is currently Chief Medical Officer at Context Therapeutics, Inc. Formerly, Dr. Chagin was Senior Vice President-Early-Stage Development at Adaptimmune Therapeutics Plc.
Education includes an undergraduate degree from the University of Pennsylvania and a doctorate from Temple University School of Medicine.
Aktive Positionen von Karen Chagin
| Unternehmen | Position | Beginn |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 09.06.2025 |
Ehemalige bekannte Positionen von Karen Chagin
| Unternehmen | Position | Ende |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | - |
Ausbildung von Karen Chagin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University School of Medicine
Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Context Therapeutics, Inc.
Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
















